Literature DB >> 16614973

De novo hepatocellular carcinoma in a patient with chronic hepatitis C 5 years after sustained virologic response to interferon/ribavirin therapy.

Kevin S Sieja1, Gregory T Everson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16614973     DOI： 10.1007/s10620-006-3176-1

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  12 in total

1.  Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma after a sustained response to interferon therapy.

Authors:  Akiko Makiyama; Yoshito Itoh; Akinori Kasahara; Yasuharu Imai; Sumio Kawata; Kentaro Yoshioka; Hirohito Tsubouchi; Kendo Kiyosawa; Shinichi Kakumu; Kiwamu Okita; Norio Hayashi; Takeshi Okanoue
Journal:  Cancer       Date:  2004-10-01       Impact factor: 6.860

Review 2.  Hepatocellular carcinoma and hepatitis C in the United States.

Authors:  Hashem B El-Serag
Journal:  Hepatology       Date:  2002-11       Impact factor: 17.425

Review 3.  Hepatitis C and hepatocellular carcinoma.

Authors:  A M Di Bisceglie
Journal:  Hepatology       Date:  1997-09       Impact factor: 17.425

Review 4.  Viruses and hepatocellular carcinoma.

Authors:  S Sherlock
Journal:  Gut       Date:  1994-06       Impact factor: 23.059

5.  Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of Hepatocarcinogenesis by Interferon Therapy.

Authors:  H Yoshida; Y Shiratori; M Moriyama; Y Arakawa; T Ide; M Sata; O Inoue; M Yano; M Tanaka; S Fujiyama; S Nishiguchi; T Kuroki; F Imazeki; O Yokosuka; S Kinoyama; G Yamada; M Omata
Journal:  Ann Intern Med       Date:  1999-08-03       Impact factor: 25.391

6.  Interferon and prevention of hepatocellular carcinoma in viral cirrhosis: an evidence-based approach.

Authors:  C Cammà; M Giunta; P Andreone; A Craxì
Journal:  J Hepatol       Date:  2001-04       Impact factor: 25.083

7.  Most of the patients with cirrhosis in Japan die from hepatocellular carcinoma.

Authors:  Y Kato; K Hamasaki; T Aritomi; K Nakao; K Nakata; K Eguchi
Journal:  Oncol Rep       Date:  1999 Nov-Dec       Impact factor: 3.906

8.  Development of small hepatocellular carcinoma 80 months after clearance of hepatitis C virus with interferon therapy.

Authors:  M Yamada; M Ichikawa; A Matsubara; Y Ishiguro; M Yamada; S Yokoi
Journal:  Eur J Gastroenterol Hepatol       Date:  2000-09       Impact factor: 2.566

9.  Hepatocellular carcinoma in HCV-infected patients awaiting liver transplantation: genes involved in tumor progression.

Authors:  Valeria R Mas; Daniel G Maluf; Richard Stravitz; Catherine I Dumur; Bradly Clark; Cheryl Rodgers; Andrea Ferreira-Gonzalez; Robert A Fisher
Journal:  Liver Transpl       Date:  2004-05       Impact factor: 5.799

10.  Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis.

Authors:  S Nishiguchi; T Kuroki; S Nakatani; H Morimoto; T Takeda; S Nakajima; S Shiomi; S Seki; K Kobayashi; S Otani
Journal:  Lancet       Date:  1995-10-21       Impact factor: 79.321
View more
  4 in total

1.  Intrahepatic cholangiocellular carcinoma and hepatocellular carcinoma developed after a 6-year sustained virological response to interferon therapy for chronic hepatitis C.

Authors:  Shinji Takashimizu; Sei-Ichiro Kojima; Junko Nagata; Yasuhiro Nishizaki; Tatehiro Kagawa; Koichi Shiraishi; Tetsuya Mine; Jun-Ichi Kaneko; Norihiro Kokudo; Norihito Watanabe
Journal:  Clin J Gastroenterol       Date:  2011-03-24

2.  Hepatocellular carcinoma after sustained virologic response in hepatitis C patients without cirrhosis on a pretreatment liver biopsy.

Authors:  Justin L Sewell; Kristine M Stick; Alexander Monto
Journal:  Eur J Gastroenterol Hepatol       Date:  2009-02       Impact factor: 2.566

3.  Hepatocellular carcinoma in Hepatitis C genotype 4 after viral clearance and in absence of cirrhosis: two case reports.

Authors:  Moutaz Derbala; Aliaa Amer
Journal:  Cases J       Date:  2009-09-15

4.  Long-term effects of antiviral therapy in patients with chronic hepatitis C.

Authors:  Tatehiro Kagawa; Emmet B Keeffe
Journal:  Hepat Res Treat       Date:  2010-09-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.